550
Participants
Start Date
May 31, 2007
Primary Completion Date
May 31, 2017
Study Completion Date
October 31, 2017
Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%
"BACTROBAN NASAL is a white to off-white ointment that contains 2.15% w/w mupirocin calcium (equivalent to 2.0% pure mupirocin free acid) in a soft white ointment base. The inactive ingredients are paraffin and a mixture of glycerin esters (SOFTISAN 649).~pHisoHex, brand of hexachlorophene detergent cleanser, is an antibacterial sudsing emulsion for topical administration.~Some randomized patients will receive mupirocin (Bactroban) nasal ointment plus hexachlorophene (pHisoHex) body washes for seven days."
Placebo
Some randomized patients will receive a placebo nasal ointment (white petroleum) and a placebo body soap with no antimicrobial activity for seven days.
Walter Reed National Military Medical Center, Bethesda
Naval Medical Center San Diego/Infectious Disease Division, San Diego
San Antonio Military Medical Center (BAMC/WHMC), San Antonio
Naval Medical Center Portsmouth, Portsmouth
Infectious Diseases Clinical Research Program
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
US Military HIV Research Program
NETWORK
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER